Sara T. Hjuler
Novo Nordisk Park, Maaloer
Aa, Denmark
Aa, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Efficient sampling of liver tissue for histological analysis of rodent MASLD/MASH models.
Journal: Histology and histopathology
Published: May 08, 2026
Choline-deficient, high-fat diet-induced MASH in Göttingen Minipigs: characterization and effects of a chow reversal period.
Journal: American journal of physiology. Gastrointestinal and liver physiology
Published: July 23, 2024
An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD).
Journal: Nature metabolism
Published: April 06, 2023
Standard procedures for blood withdrawal in conscious male rats induce stress and profoundly affect glucose tolerance and secretion of glucoregulatory hormones.
Journal: Molecular metabolism
Published: December 07, 2022
Hepatocyte mARC1 promotes fatty liver disease.
Journal: JHEP reports : innovation in hepatology
Published: September 02, 2022
Addition of trans fat and alcohol has divergent effects on atherogenic diet-induced liver injury in rodent models of steatohepatitis.
Journal: American journal of physiology. Gastrointestinal and liver physiology
Published: January 07, 2020
Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis - Effects of a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a glucagon-like peptide-1 analogue.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: September 14, 2018
Assessment of liver fibrosis progression and regression by a serological collagen turnover profile.
Journal: American journal of physiology. Gastrointestinal and liver physiology
Published: August 31, 2018
The Dual Amylin- and Calcitonin-Receptor Agonist KBP-042 Works as Adjunct to Metformin on Fasting Hyperglycemia and HbA1c in a Rat Model of Type 2 Diabetes.
Journal: The Journal of pharmacology and experimental therapeutics
Published: March 13, 2017
Optimization of tolerability and efficacy of the novel dual amylin and calcitonin receptor agonist KBP-089 through dose escalation and combination with a GLP-1 analog.
Journal: American journal of physiology. Endocrinology and metabolism
Published: November 18, 2016
A novel dual amylin and calcitonin receptor agonist, KBP-089, induces weight loss through a reduction in fat, but not lean mass, while improving food preference.
Journal: British journal of pharmacology
Published: June 29, 2016
The dual amylin- and calcitonin-receptor agonist KBP-042 increases insulin sensitivity and induces weight loss in rats with obesity.
Journal: Obesity (Silver Spring, Md.)
Published: January 11, 2016
Last Updated: 09/26/2026